- Celebrity news
- Fundraising news
- Policy news
- Science news
Researchers identify key barriers to underrepresented people taking part in dementia clinical trials
More must be done to tackle the barriers to recruitment and retention of participants for clinical trials from traditionally underserved communities.
Researchers have highlighted a link between cases of COVID-19 that include neurological symptoms with biological markers of Alzheimer’s disease. These results make it clear that more long-term follow-up is needed
Researchers in the US, published in the journal Neurology, suggest that a diet high in compounds known as flavonoids are linked with improved memory.
“Research presented #AAIC21 suggests transgender adults are more likely to report experience of worsening memory or thinking.
Researchers believe population growth and aging are driving factors as dementia cases are set to triple by 2050.
Alzheimer’s Drug Discovery Foundation Investment Boosts Search for Digital Biomarkers for Early Alzheimer’s
$2 million of funding aims to develop a digital Toolkit of apps and wearables to detect the very earliest stage of Alzheimer’s.
Call comes as researchers present findings at world’s largest dementia research conference Pollutants associated with Alzheimer’s protein in study Reduction in pollution linked with improved brain health and reduction in dementia cases Research presented today (Monday 26 July) at the 2021 Alzheimer’s Association International Conference (AAIC) in Colorado links air pollution to brain changes associated…
Scientists at UCL have developed a programme, which helps older people make lifestyle changes to support their health and hopefully reduce the risk of developing dementia through online video support groups. Our expert’s opinion Dr Susan Mitchell, Head of Policy at Alzheimer’s Research UK, said: “The ongoing COVID-19 pandemic is having a disproportionate impact on…
Research links the cocktail party problem with an increased risk of dementia in a study conducted at the University of Oxford. Alzheimer’s Research UK comments on the findings.